Argent Biopharma Ltd (RGT)

Not featured in screeners

Not featured in screeners

Top insiders

Company data & Insiders

Download results Settings

Roby Zomer

Managing Director and Chief Executive Officer

1 purchase — total 1,640,000 AUD

Buy 15 Oct 2024

Value A$995,102.53 | Price 56.13 | Shares 63,613

Roby Zomer

Managing Director and Chief Executive Officer

1 purchase — total 503,400 AUD

Buy 10 Sep 2024

Value A$2,407,498.14 | Price 28.77 | Shares 94,452

Amir Polak

Chief Pharmaceutical Development Officer

1 sale — total 2,365 AUD

Sale 10 Apr 2024

Value A$2,365.00 | Price 0.43 | Shares 5,500

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2024-10-15	2024-10-15	B Purchase	Roby Zomer Managing Director and Chief Executive Officer Executive Director	63,613 56.13 A$995,103	63,613	56.13	A$995,103
2024-09-12	2024-09-10	B Purchase	Roby Zomer Managing Director and Chief Executive Officer Executive Director	94,452 28.77 A$2,407,498	94,452	28.77	A$2,407,498
2024-04-10	2024-04-10	S Sale	Amir Polak Chief Pharmaceutical Development Officer Officer	26,105 399.86 A$3,535,760	26,105	399.86	A$3,535,760

More insider trading research around Argent Biopharma Ltd